4H-1,3-Thiazin-4-one,2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide cas no:80-77-3
Synonyms: 4H-1,3-Thiazin-4-one,2-(p-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide (6CI,7CI,8CI); (?à)-Chlormezanone; (?à)-Fenarol;2-(4-Chlorophenyl)-3-methyl-4-metathiazanone-1,1-dioxide;2-(p-Chlorophenyl)-3-methyl-1,3-perhydrothiazin-4-one 1,1-dioxide;2-(p-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide;2-(p-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide; Alinam;Banabin-Sintyal; Chlormethazanone; Chlormethazone; Chlormezanone;Dichloromezanone; Fenarol; Lobak; Mio-Sed; Muskel Trancopal; NSC 169108;Phenarol; Rexan; Rilansyl; Rilaquil; Rilasol; Rilassol; Supotran; Suprotran;Tanafol; Trancopal; Trancote; Transanate; dl-Chlormezanone
Name4H-1,3-Thiazin-4-one,2-(4-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide
CAS80-77-3
Synonyms4H-1,3-Thiazin-4-one,2-(p-chlorophenyl)tetrahydro-3-methyl-, 1,1-dioxide (6CI,7CI,8CI); (?à)-Chlormezanone; (?à)-Fenarol;2-(4-Chlorophenyl)-3-methyl-4-metathiazanone-1,1-dioxide;2-(p-Chlorophenyl)-3-methyl-1,3-perhydrothiazin-4-one 1,1-dioxide;2-(p-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide;2-(p-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide; Alinam;Banabin-Sintyal; Chlormethazanone; Chlormethazone; Chlormezanone;Dichloromezanone; Fenarol; Lobak; Mio-Sed; Muskel Trancopal; NSC 169108;Phenarol; Rexan; Rilansyl; Rilaquil; Rilasol; Rilassol; Supotran; Suprotran;Tanafol; Trancopal; Trancote; Transanate; dl-Chlormezanone
EINECS(EC#)201-307-4
Molecular FormulaC11H12 Cl N O3 S
Molecular Weight273.73
refractive index1.58
storage tempStore at RT
Safety
Poison by intraperitoneal and subcutaneous routes. Moderately toxic by ingestion. Human systemic effects by ingestion: dilation of the pupils, ataxia (loss of muscle coordination), and coma. When heated to decomposition it emits very toxic fumes of SOx, NOx, and Cl−.Safety information of Chlormezanone (CAS NO.80-77-3):
RTECS XJ1050000
1. |
|
orl-man TDLo:157 mg/kg:EYE,CNS
|
|
BMJOAE British Medical Journal. 292 (1986),732. |
2. |
|
orl-rat LD50:605 mg/kg
|
|
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 130 (1961),280. |
3. |
|
ipr-rat LD50:370 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 17 (1967),242. |
4. |
|
orl-mus LD50:600 mg/kg
|
|
OYYAA2 Oyo Yakuri. Pharmacometrics. 9 (1975),601. |
5. |
|
ipr-mus LD50:570 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 17 (1967),242. |
6. |
|
scu-mus LD50:322 mg/kg
|
|
APTOA6 Acta Pharmacologica et Toxicologica. 19 (1962),247. |
7. |
|
orl-dog LD50:500 mg/kg
|
|
TXAPA9 Toxicology and Applied Pharmacology. 1 (1959),168. |
8. |
|
ipr-dog LD50:500 mg/kg
|
|
TXAPA9 Toxicology and Applied Pharmacology. 1 (1959),168. |
9. |
|
ipr-gpg LD50:600 mg/kg
|
|
TXAPA9 Toxicology and Applied Pharmacology. 1 (1959),168. |